Next generation sequencing in clinical diagnostics: experiences of early adopters

Affiliations

• ¹ Associate Professor of Pathology, University of Utah School of Medicine, Salt Lake City, UT; Medical Director, Molecular Genetics, ARUP Laboratories, Salt Lake City, UT; lyone@aruplab.com.
• ² Professor and Chair, Department of Laboratory Medicine and Pathology and President and CEO, Mayo Medical Laboratories, Mayo Clinic, Rochester, MN; Current affiliation: Quest Diagnostics (10/1/14);
• ³ Managing Director, GeneDx, Gaithersburg, MD;
• ⁴ Assistant Director, Pathology Translational Research Laboratory, Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, Oregon;
• ⁵ Director, Center for Clinical and Translational Metagenomics, Brigham & Women's Hospital and Associate Professor of Pathology, Harvard Medical School, Boston, MA;
• ⁶ Chief Medical Officer, 23andMe, Inc. and.
• ⁷ Associate Professor, Pathology and Immunology, Pediatrics and Genetics, Director of Cytogenomics and Molecular Pathology, Washington University School of Medicine, St. Louis, MO;
• ⁸ Department of Pathology & Knight Cancer Institute, Oregon Health & Science University, Portland, OR;
• ⁹ Department of Pathology and Laboratory Medicine. Women & Infants Hospital, Alpert Medical School at Brown University, Providence, RI.